Infertility Treatments in Women with Polycystic Ovary Syndrome
- سال انتشار: 1398
- محل انتشار: پانزدهمین کنگره بین المللی زنان و مامایی ایران
- کد COI اختصاصی: COBGY15_116
- زبان مقاله: انگلیسی
- تعداد مشاهده: 486
نویسندگان
MSc of Midwifery Faculty Member of Nursing and Midwifery school, Qazvin University of Medical Science, Qazvin, Iran
Gynecologist & obstetrics, Faculty Member of Medicine School, Qazvin University of Medical Science, Qazvin, Iran
چکیده
Background: Polycystic ovary syndrome is one of the most common causes of female infertility, affecting 5-10% of the population. Women with PCOS manifest hyperandrogenism, hyperinsulinemia, low-grade systemic inflammation, and polycystic ovaries.Material and Method : The aim of this review is to discuss the medical approach to the management of PCO that led to infertility. This study was performed of a systematic literature by using the electronic databases PubMed, Cochrane, Embase, ProQuest and Science direct from 2010 to present.Result: In clomiphene-citrate-resistant anovulatory women with polycystic ovary syndrome (PCOS) and no other infertility factors, either metformin combined with clomiphene citrate or gonadotrophins could be used as a second-line pharmacological therapy, although gonadotrophins are more effective.Gonadotrophins could also be used as a second-line pharmacological therapy in anovulatory women with PCOS and clomiphene-citrate-failure. Laparoscopic ovarian surgery can also be used as a second-line therapy for ovulation induction in anovulatory women with clomiphene-citrate-resistant PCOS and no other infertility factors. The usefulness of letrozole as a second-line pharmacological treatment for ovulation induction in clomiphene-citrate-resistant women with PCOS requires further research. In terms of improving fertility, both pharmacological anti-obesity agents and bariatric surgery should be considered an experimental therapy in anovulatory women with PCOS and no other infertility factors. Where first- or second-line ovulation induction therapies have failed, in vitro fertilization (IVF)/ intracytoplasmic sperm injection (ICSI) could be offered as a third-line therapy in women with PCOS in the absence of an absolute indication for IVF/ICSI. For women with PCOS undergoing IVF/ICSI treatment, the gonadotropin-releasing hormone (GnRH) antagonist protocol is preferred and an elective frozen embryo transfer strategy could be considered. In assisted conception units with sufficient expertise, in-vitro maturation (IVM) of oocytes could be offered to women with PCOS.Conclusion: treatment according to the patient's condition and stage of the disease should be done.Keywords: IVF; infertility; polycystic ovary syndrome; surgery Reference: Electronic.databases: PubMed, Cochrane, Embase, ProQuest and Science direct from 2010 toکلیدواژه ها
مقالات مرتبط جدید
- Centering pregnancy مزایا،چالش ها و راه های بکارگیری آن
- Respectful Maternity Care and Its Influence on Birth Outcomes: A Narrative Review
- بررسی ناهنجاری ژنتیکی در ناباروری مردان در دهه های اخیر
- کلیدهای طلایی بارداری سالم: تغذیه مناسب و مصرف صحیح مکمل ها
- The Critical Window: Meeting Infant Nutrient Needs during Complementary Feeding
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.